Information Journal Paper
APA:
Copy. (2020). Combination therapy of doxorubicin and quercetin on multidrug-resistant breast cancer and their sequential delivery by reduction-sensitive hyaluronic acid-based conjugate/d-α,-tocopheryl poly (ethylene glycol) 1000 succinate mixed micelles. MOLECULAR PHARMACEUTICS, 17(4), 1415-1427. SID. https://sid.ir/paper/1091351/en
Vancouver:
Copy. Combination therapy of doxorubicin and quercetin on multidrug-resistant breast cancer and their sequential delivery by reduction-sensitive hyaluronic acid-based conjugate/d-α,-tocopheryl poly (ethylene glycol) 1000 succinate mixed micelles. MOLECULAR PHARMACEUTICS[Internet]. 2020;17(4):1415-1427. Available from: https://sid.ir/paper/1091351/en
IEEE:
Copy, “Combination therapy of doxorubicin and quercetin on multidrug-resistant breast cancer and their sequential delivery by reduction-sensitive hyaluronic acid-based conjugate/d-α,-tocopheryl poly (ethylene glycol) 1000 succinate mixed micelles,” MOLECULAR PHARMACEUTICS, vol. 17, no. 4, pp. 1415–1427, 2020, [Online]. Available: https://sid.ir/paper/1091351/en